These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34536122)

  • 1. GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.
    Sievers P; Stichel D; Sill M; Schrimpf D; Sturm D; Selt F; Ecker J; Kazdal D; Miele E; Kranendonk MEG; Tops BBJ; Kohlhof-Meinecke P; Beschorner R; Kramm CM; Hasselblatt M; Reifenberger G; Capper D; Wesseling P; Stenzinger A; Milde T; Korshunov A; Witt O; Pfister SM; Wick W; von Deimling A; Jones DTW; Sahm F
    Acta Neuropathol; 2021 Dec; 142(6):1065-1069. PubMed ID: 34536122
    [No Abstract]   [Full Text] [Related]  

  • 2. GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
    Richardson TE; Tang K; Vasudevaraja V; Serrano J; William CM; Mirchia K; Pierson CR; Leonard JR; AbdelBaki MS; Schieffer KM; Cottrell CE; Tovar-Spinoza Z; Comito MA; Boué DR; Jour G; Snuderl M
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1089-1099. PubMed ID: 31626289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic GOPC-ROS1 Fusion Identified in a Congenital Glioblastoma Case.
    Whiteway SL; Betts AM; O'Neil ER; Green AL; Gilani A; Orr BA; Mathis DA
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):e813-e818. PubMed ID: 31929384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
    Suehara Y; Arcila M; Wang L; Hasanovic A; Ang D; Ito T; Kimura Y; Drilon A; Guha U; Rusch V; Kris MG; Zakowski MF; Rizvi N; Khanin R; Ladanyi M
    Clin Cancer Res; 2012 Dec; 18(24):6599-608. PubMed ID: 23052255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GOPC-ROS1 mosaicism in agminated Spitz naevi: report of two cases.
    Goto K; Pissaloux D; Kauer F; Huriet V; Tirode F; de la Fouchardière A
    Virchows Arch; 2021 Sep; 479(3):559-564. PubMed ID: 33733342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.
    Davare MA; Henderson JJ; Agarwal A; Wagner JP; Iyer SR; Shah N; Woltjer R; Somwar R; Gilheeney SW; DeCarvalo A; Mikkelson T; Van Meir EG; Ladanyi M; Druker BJ
    Clin Cancer Res; 2018 Dec; 24(24):6471-6482. PubMed ID: 30171048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of GOPC-ROS1 (FIG-ROS1) rearrangement in adult human gliomas.
    Karayan-Tapon L; Cortes U; Rivet P; Jermidi C; Vassal G; Wager M; Taillandier L
    Eur J Cancer; 2014 Sep; 50(13):2364-6. PubMed ID: 24999209
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma.
    Nakano Y; Tomiyama A; Kohno T; Yoshida A; Yamasaki K; Ozawa T; Fukuoka K; Fukushima H; Inoue T; Hara J; Sakamoto H; Ichimura K
    Brain Tumor Pathol; 2019 Jan; 36(1):14-19. PubMed ID: 30350109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal papillary adenocarcinoma harboring a fusion of ROS1 with GOPC: A case report.
    Wang J; Luo S; Li Y; Zheng H
    Medicine (Baltimore); 2021 Jan; 100(3):e24377. PubMed ID: 33546077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor.
    Kiehna EN; Arnush MR; Tamrazi B; Cotter JA; Hawes D; Robison NJ; Fong CY; Estrine DB; Han JH; Biegel JA
    J Neurosurg Pediatr; 2017 Jul; 20(1):51-55. PubMed ID: 28387643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion-Mutated Breast Cancer.
    O'Neil SR; Weber GA; Deming DA; Burkard ME; Kenny PA; Richmond CS; Parsons BM
    JCO Precis Oncol; 2023 Jul; 7():e2300174. PubMed ID: 37487149
    [No Abstract]   [Full Text] [Related]  

  • 12. GOPC-ROS1 Rearrangement as an Acquired Resistance Mechanism to Osimertinib and Responding to Crizotinib Combined Treatments in Lung Adenocarcinoma.
    Zeng L; Yang N; Zhang Y
    J Thorac Oncol; 2018 Jul; 13(7):e114-e116. PubMed ID: 29935846
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case Report.
    Dong D; Shen G; Da Y; Zhou M; Yang G; Yuan M; Chen R
    Oncologist; 2020 Nov; 25(11):e1720-e1724. PubMed ID: 32652753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROS1 fusions in cancer: a review.
    Uguen A; De Braekeleer M
    Future Oncol; 2016 Aug; 12(16):1911-28. PubMed ID: 27256160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infant-type hemispheric glioma with EEF1G-ROS1 fusion: report of a case].
    Gao M; Wang LM; Piao YS; Teng LH
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):408-410. PubMed ID: 36973207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.
    Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X
    Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel
    Deland L; Keane S; Bontell TO; Fagman H; Sjögren H; Lind AE; Carén H; Tisell M; Nilsson JA; Ejeskär K; Sabel M; Abel F
    Cancer Genomics Proteomics; 2022; 19(6):711-726. PubMed ID: 36316040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases.
    Huang RSP; Haberberger J; Sokol E; Schrock AB; Danziger N; Madison R; Trabucco S; Jin D; Pavlick D; Ramanan V; Hole K; McGregor K; Venstrom J; Ross JS
    Int J Cancer; 2021 Apr; 148(7):1778-1788. PubMed ID: 33336398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Mass in a Young Male With Ollier Disease.
    Govalan R; Guindi M; Yang JD
    Gastroenterology; 2021 Nov; 161(5):e4-e5. PubMed ID: 33812890
    [No Abstract]   [Full Text] [Related]  

  • 20. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.
    Pan Y; Zhang Y; Li Y; Hu H; Wang L; Li H; Wang R; Ye T; Luo X; Zhang Y; Li B; Cai D; Shen L; Sun Y; Chen H
    Lung Cancer; 2014 May; 84(2):121-6. PubMed ID: 24629636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.